Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets
Figure 2.The Kaplan-Meier survival curve was applied to investigate the prognosis of SHCBP1 expression in pan-cancer. (A) Overall survival (B) Disease-free survival.